When was DeepWise founded?

DeepWise was founded in 2017 and raised its 1st funding round within a year of its incorporation.

Where is DeepWise located?

DeepWise is headquartered in Beijing, China.

How many employees does DeepWise have?

As of May 31, 2026, the latest employee count at DeepWise is 55.

Is DeepWise a funded company?

DeepWise is a funded company, having raised a total of $115M across 8 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Apr 2017.

When was the latest funding round of DeepWise?

DeepWise's latest funding was a $***** Series D round on Jun 26, 2026, with participation from 4 investors.

Where does DeepWise rank among its competitors?

DeepWise ranks 21st amongst 322 active competitors, of which 89 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of DeepWise?

DeepWise's top competitors include PAIGE, PathAI and Pictor Labs. Among them, DeepWise secured the most recent funding round in June, 2026.

DeepWise - 2026 Company Profile, Team, Funding & Competitors

Company Details

DeepWise is a developer of AI-based radiology image solutions primarily for cancer diagnosis. Its solution uses a deep learning framework to assist in medical imaging diagnosis. Claims to help in the diagnosis of breast cancer, stroke, emergency fracture, prostate cancer, and lung cancer. The company offers the cloud-based image platform, and also helps in clinical decision making and research.

Website: www.deepwise.com
Social
Email ID: *****@deepwise.com
Phone Number: +86 **********

Key Metrics

Founded Year

2017

Location

Beijing, China

Stage

Series D

Total Funding

$115M in 8 rounds

Latest Funding Round

Series D, Jun 26, 2026, $*****

Investors

Legend Capital & 15 more

Ranked

21^st among 322 active competitors

Employee Count

55 as on May 31, 2026

Similar Companies

Abridge Inc & 2623 more

View DeepWise's full profile

DeepWise has raised a total funding of $115M over 8 rounds. Its first funding round was on Apr 2017. Its latest funding round was a Series D round on Jun 26, 2026 for $*****. 4 investors participated in its latest round. DeepWise has 16 institutional investors.

Here is the list of recent funding rounds of DeepWise:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 26, 2026	2167387	Series D	8472127	2336963	2786211	3926939
Feb 08, 2025	8040410	Series D	2953721	2667083	3959916	Legend Capital & 1 more
May 11, 2021	3333616	Series C	7776901	3425530	CICC Capital	Legend Capital & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of DeepWise's funding rounds and investors

The founders of DeepWise are Qiao Xin and Yiming Li.

Here are the details of DeepWise's key team members:

Qiao Xin: Co-Founder & CEO of DeepWise.
Contact Info: 1 email address
Yiming Li: Co-Founder & CTO of DeepWise.

View details of DeepWise's Founder profiles and Board Members

DeepWise's employee count trend

DeepWise has 55 employees as of May 26. Here is DeepWise's employee count trend over the years:

Uncover DeepWise's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of DeepWise include PAIGE, PathAI and Pictor Labs. Here is the list of Top 10 competitors of DeepWise, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	71/100
2nd	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Merck Global Health Innovation Fund ... & 22 others	71/100
3rd	Pictor Labs 2019, Los Angeles (United States), Series B	AI-based solutions for pathological image analysis	$48.8M	Insight Partners, LabCorp & 4 others	64/100
4th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	63/100
5th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Businessfinland, Ascend Capital Partners & 8 others	63/100
6th	Lunit 2013, Seoul (South Korea), Public	Developer of artificial intelligence solutions for cancer detection and treatment	$135M	InterVest, Shinhan Investment Corp & 24 others	62/100
7th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	61/100
8th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	61/100
9th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Action Potential Venture Capital ... & 12 others	61/100
10th	Enspectra Health 2014, Mountain View (United States), Series A	Developer of medical devices for tissue imagining and cancer detection	$15.5M	Foothill Ventures, Heuristic Capital Partners ... & 6 others	59/100
21st	DeepWise 2017, Beijing (China), Series D	Developer of AI-based radiology image solutions primarily for cancer diagnosis	$115M	DHVC, FengHe Group & 14 others	57/100